These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 980763)

  • 21. [Immunological studies of the mechanism of the therapeutic action of azathioprine and of indomethacin in chronic active glomerulonephritis and the nephrotic syndrome].
    Campanacci L; Castellani A; Gambari PF; Huber W; Fagiolo U; Vesco F; Contini MG; Rebecca L
    Minerva Nefrol; 1970; 17(4):127-50. PubMed ID: 4102147
    [No Abstract]   [Full Text] [Related]  

  • 22. Urinary excretion of fibrinogen-fibrin-related antigen in glomerulonephritis: effect of indomethacin.
    Dotremont G; Vermylen J; Donati MB; Van Damme B; Michielsen P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):829-44. PubMed ID: 4803317
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the use of indomethacin in the treatment of renal diseases in childhood].
    Varese LA; Antoniola P
    Minerva Pediatr; 1970 Jul; 22(28):1440-3. PubMed ID: 5515768
    [No Abstract]   [Full Text] [Related]  

  • 24. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 25. [Indomethacin in nephropathies in children. Apropos of 21 cases].
    Pierron H; Manassero J; Vaillaud JC; Paglia R; Orsini A
    Pediatrie; 1971 Mar; 26(2):167-73. PubMed ID: 5554434
    [No Abstract]   [Full Text] [Related]  

  • 26. Indomethacin and platelet aggregation in chronic glomerulonephritis: existence of non-responders.
    De Gaetano G; Vermylen J; Donati MB; Dotremont G; Michielsen P
    Br Med J; 1974 May; 2(5914):301-3. PubMed ID: 4827105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of treatment with corticosteroids and indomethacin on proteinuria].
    Michielsen P; Lambert PP
    J Urol Nephrol (Paris); 1967; 73(4):340-55. PubMed ID: 6066085
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
    Lagrue G; Masbernard A; Giudicelli C; Hirbec G
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1434-9. PubMed ID: 4614821
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of indomethacin on erythrocyturia in chronic glomerulonephritis].
    Orban A; Slugen I
    Vnitr Lek; 1983 Nov; 29(11):1102-6. PubMed ID: 6659386
    [No Abstract]   [Full Text] [Related]  

  • 30. [Results of indomethacin treatment in protracted glomerulonephritis in children].
    Rowecka-Trzebicka K; Siarkiewicz K; Wojnarowski M
    Pediatr Pol; 1971 Dec; 46(12):1527-31. PubMed ID: 5136662
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of benazepril and valsartan alone or in combination on proteinuria in chronic glomerular disease].
    Zhang DY; Yang YL; Chen WD; Huang YY; Li LH; Wang YW; Zhu XJ; Xu HH; Yang LC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):762-3. PubMed ID: 18093443
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative study on the activity of various anti-inflammatory agents in chronically developing glomerulonephritis].
    Giudicelli CP; Lagrue G; Masbernard A; Hirbec G
    J Urol Nephrol (Paris); 1975 Sep; 81(9):673-90. PubMed ID: 1243552
    [No Abstract]   [Full Text] [Related]  

  • 33. [Stage-by-stage treatment of patients with chronic glomerulonephritis].
    Androsova SO; Nevraeva OG
    Urol Nefrol (Mosk); 1977; (2):18-23. PubMed ID: 855043
    [No Abstract]   [Full Text] [Related]  

  • 34. [Kidney and hemostasis. II. Therapeutic approach to various immunological renal diseases with blood platelet aggregation inhibitors].
    De Gaetano G; Donati MB; Vermylen J; Dotremont G; Michielsen P
    Clin Ter; 1972 Dec; 63(5):425-35. PubMed ID: 4566418
    [No Abstract]   [Full Text] [Related]  

  • 35. [The indomethacin treatment of glomerulonephritis patients with the urinary syndrome].
    Dorets'kyĭ VV
    Vrach Delo; 1991 Jul; (7):101-3. PubMed ID: 1771818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Criteria for the outcome of treatment of chronic glomerulonephritis and the evaluation of the effectiveness of current therapeutic methods].
    Ratner MIa; Tomilina NA; Samokhina NM
    Ter Arkh; 1978; 50(1):81-7. PubMed ID: 635805
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of indometacin for treating diffuse glomerulonephritis under experimental and clinical conditions.
    Vihert AM; Glezer GA; Megrelishvili RI; Ryff IM
    Arzneimittelforschung; 1973 Jul; 23(7):991-6. PubMed ID: 4800460
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of primary glomerulopathies with an anti-inflammatory substance: indomethacin].
    Lagrue G; Bariéty J; Druet P; Milliez P
    Ann Med Interne (Paris); 1971 Jan; 122(1):77-84. PubMed ID: 5548151
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of diffuse glomerulonephritis with indomethacin under hospital and ambulatory conditions].
    Glezer GA; Vikhert AM; Megreliashvili RI
    Sov Med; 1973 Nov; 36(11):99-103. PubMed ID: 4787435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.